Skip to content
JournalsWorldThe Global Research Discovery Platform
Login Sign Up
SCHOLARLY PUBLICATION ✓ Open Access

The IASLC Lung Cancer Staging Project: A Proposal for a New International Lymph Node Map in the Forthcoming Seventh Edition of the TNM Classification for Lung Cancer

Valerie W. Rusch, Hisao Asamura, Hirokazu Watanabe, Dorothy J. Giroux, Ramón Rami–Porta, Peter Goldstraw

📖 Journal of Thoracic Oncology → 📅 2009-05-01 🔗 DOI: 10.1097/jto.0b013e3181a0d82e
View Journal Profile → ⬇ Download PDF View Official Paper ↗

📄 Abstract

The abstract has not yet been added. Use the official source link for the complete publication record.

🔬 Related Research Papers

Journal of Thoracic Oncology

Updated Efficacy and Safety Data and Impact of the EML4-ALK Fusion Variant on the Efficacy of Alectinib in Untreated ALK-Positive Advanced Non–Small Cell Lung Cancer in the Global Phase III ALEX Study

D. Ross Camidge, Rafał Dziadziuszko et al. 2019-03-20 · Read paper → Journal of Thoracic Oncology

IMpower150 Final Overall Survival Analyses for Atezolizumab Plus Bevacizumab and Chemotherapy in First-Line Metastatic Nonsquamous NSCLC

Mark A. Socinski, Makoto Nishio et al. 2021-07-24 · Read paper → Journal of Thoracic Oncology

Atezolizumab in Combination With Carboplatin and Nab-Paclitaxel in Advanced Squamous NSCLC (IMpower131): Results From a Randomized Phase III Trial

Robert M. Jotte, Federico Cappuzzo et al. 2020-04-14 · Read paper → Journal of Thoracic Oncology

The IASLC Lung Cancer Staging Project: Proposals for the Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer

Ramón Rami–Porta, Vanessa Bolejack et al. 2015-06-24 · Read paper → Journal of Thoracic Oncology

The International Epidemiology of Lung Cancer: Geographical Distribution and Secular Trends

Danny R. Youlden, Susanna M. Cramb, Peter D. Baade 2008-08-01 · Read paper → Journal of Thoracic Oncology

PD-L1 Immunohistochemistry Comparability Study in Real-Life Clinical Samples: Results of Blueprint Phase 2 Project

Ming‐Sound Tsao, Keith M. Kerr et al. 2018-05-22 · Read paper → Journal of Thoracic Oncology

Checkpoint Inhibitors in Metastatic EGFR- Mutated Non–Small Cell Lung Cancer—A Meta-Analysis

Chee Khoon Lee, Johnathan Man et al. 2016-10-19 · Read paper → Journal of Thoracic Oncology

Hypofractionated Stereotactic Radiotherapy (HypoFXSRT) for Stage I Non-small Cell Lung Cancer: Updated Results of 257 Patients in a Japanese Multi-institutional Study

Hiroshi Onishi, Hiroki Shirato et al. 2007-07-01 · Read paper → Journal of Thoracic Oncology

PD-L1 Immunohistochemistry Assays for Lung Cancer: Results from Phase 1 of the Blueprint PD-L1 IHC Assay Comparison Project

Fred R. Hirsch, Abigail McElhinny et al. 2016-11-29 · Read paper → Journal of Thoracic Oncology

Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology

Neal Ian Lindeman, Philip T. Cagle et al. 2013-04-03 · Read paper → Journal of Thoracic Oncology

Pulmonary Pathology of Early-Phase 2019 Novel Coronavirus (COVID-19) Pneumonia in Two Patients With Lung Cancer

Sufang Tian, Weidong Hu et al. 2020-02-27 · Read paper → Journal of Thoracic Oncology

A Prospective, Molecular Epidemiology Study of EGFR Mutations in Asian Patients with Advanced Non–Small-Cell Lung Cancer of Adenocarcinoma Histology (PIONEER)

Yuankai Shi, Joseph S. K. Au et al. 2014-01-13 · Read paper →